Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
JNJ Coverage
Event
Johnson & Johnson (JNJ) Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
Apr 10, 2026
News
Johnson & Johnson likely to report mixed results for Q1 FY26
Apr 7, 2026
Event
Johnson & Johnson (JNJ) Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
Apr 7, 2026
Event
Johnson & Johnson (JNJ) ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis
Mar 28, 2026
Transcript
Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript
Jan 26, 2026
Transcript
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript
Jan 22, 2026
News
Infographic: How Johnson & Johnson (JNJ) performed in Q4 2025
Jan 21, 2026